MCRB Seres Therapeutics Inc

Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.

$20.57  +0.01 (0.05%)
As of 04/09/2021 15:59:09 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/26/2015
Outstanding shares:  91,549,412
Average volume:  969,341
Market cap:   $1,884,086,899
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    81750R102
ISIN:        US81750R1023
Sedol:      BYNQNP8
Valuation   (See tab for details)
PE ratio:   -21.14
PB ratio:   10.77
PS ratio:   56.72
Return on equity:   -51.00%
Net income %:   -268.33%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy